(−) -Myrtenal
This small molecule research compound has been shown to reduce hyperglycemia in diabetic rat models. Its mechanism involves Akt-mediated upregulation of GLUT2 transporter expression in skeletal muscle and liver tissues, making it a candidate for investigating glucose metabolism pathways in both in vivo and in vitro experimental systems.
Product Specifications
CAS Number
18486-69-6
Product Name Alternative
Akt, (1R) - (−) -Myrtenal, (?) -Myrtenal, (−) Myrtenal, (−) -Myrtenal, (−) Myrtenal, diabetic, inhibit, Inhibitor, hyperglycemia, GLUT2, terpene, Protein kinase B, PKB
Field of Research
Signal Transduction
Purity
97.65% (May vary between batches)
Solubility
DMSO:30 mg/mL (199.71 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (13.31 mM)
Smiles
CC1 (C) [C@@H]2C[C@H]1C (C=O) =CC2
Molecular Formula
C10H14O
Molecular Weight
150.22
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC881924-100 1x 100 µL
P53 Tumor Suppressor Protein (PCRP-TP53-2A10), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
5722-AAT 3x 1 mg
ReadiLink™ Rapid Cy3 Antibody Labeling Kit *Production Scale*
Sign In for Pricing
View Details